Prelims level : Science & Technology- Biotechnology Mains level : GS-III- Science and Technology- developments and their applications and effects in everyday life; Awareness in the fields of Biotechnology
No Set Found with this ID

Why in news?

  • Genes from genetically-modified Aedes aegypti mosquito were found to have been transferred to naturally-occurring A. aegypti mosquito population in three areas in Brazil where transgenic mosquitoes were released.

Transgenic mosquitoes:

  • A transgenic Mosquito is one that contains a gene or genes which have been artificially inserted instead of the mosquito acquiring them through reproduction.
  • Transgenic strains of mosquitoes were developed to
  • replace or suppress wild vector populations
  • reduce transmission
  • deliver public health gains are an imminent prospect.


  • About 4,50,000 transgenic male mosquitoes were released each week for 27 months (June 2013 to September 2015) in three areas in Brazil.
  • Transgenic mosquitoes (TMs) were developed to minimize/eliminate the mosquito borne diseases.
  • Genetic analysis of naturally occurring mosquitoes were done prior to the release and at six, 12, and 27-30 months after the releases.


  • A. aegypti mosquitoes are responsible for transmitting dengue, chikungunya and Zika virus.
  • Researchers from Yale University studied 347 naturally-occurring aegypti mosquitoes for transfer of genes from the transgenic insects.
  • The transgenic strains can be distinguished from naturally-occurring mosquitoes by using fluorescent lights and filters.
  • They found that some transgenic genes were found in 10-60% of naturally-occurring mosquitoes.
  • Also, the naturally occurring aegypti mosquitoes carrying some genes of the transgenic mosquitoes were able to reproduce in nature and spread to neighbouring areas 4 km away.


  • As per claims made by the British company Oxitec Ltd, which had developed the technology and field-tested it in several countries,
  • The genetic strategy employed to control aegypti population known as RIDL (the Release of Insects carrying Dominant Lethal genes) is supposed to only reduce the population of the naturally occurring A. aegypti mosquitoes and not affect or alter their genetics.
  • Also, offspring are not supposed to grow to adult mosquitoes and reproduce.
  • The claim was that genes from the release strain would not get into the general population because offspring would die. But that did not happen.
  • The genetic strategy works on the premise that the transgenic male mosquitoes released frequently in large numbers would compete with the naturally occurring male mosquitoes to mate with the females.
  • Offspring from the mating of transgenic male mosquito and naturally occurring female mosquito do not survive to the adult stage.
  • This is because tetracycline drug, which prevents the dominant lethal gene from producing the lethal protein during rearing in labs, is not present in sufficient quantity in nature.
  • In the absence of tetracycline, there is overproduction of the lethal protein causing the larvae to die.
  • At present, it is unclear if the presence of transgenic mosquito genes in the natural population will affect the disease transmission capacity or make mosquito control efforts more difficult.
Share Socially